GENE ONLINE|News &
Opinion
Blog

Find Your Next Bio-Business Partners at BIO Asia–Taiwan 2020

by GeneOnline
Share To

Bioindustry entrepreneurs and early-stage investors?
We’ve got you covered at BIO Asia–Taiwan

Are you an entrepreneur wanting to get a foothold in the industry? Looking for opportunities at the startup stage? Searching for early-stage and license-ready medical innovations? At BIO Asia–Taiwan 2020 Online + Live, we have you covered, with a full schedule of company presentations, entrepreneur workshops, and three days of start-up introductions at our all-new ‘Entrepreneur Pitch’ sessions. It’s a bonanza of early-stage offerings and opportunity!

Part of the workshop series, Friday 24 July, is Workshop 1, Technology and Entrepreneurship, covering the skills and technologies essential to the business. Upgrade your entrepreneur skill set at this essential session!

For the first three days, 22 to 24 July, ‘Entrepreneur Pitch’ sessions 1, 2 and 3 will showcase startups coming out of SPARK Asia, BMCC (BioMed Commercialization Center), and BEST (Biomedical Ecosystem Development Office in Taiwan) incubators. Uncover the very latest early-stage innovations from these up-and-coming startup teams, and get a head start on your competitors!

And over the same three days, six sessions of Company Presentations from the best of Asia and around the world will be held; 60+ companies in total holding 10 min video presentations. These are companies ready for business NOW! Don’t miss out, find your next bio-business partner at BIO Asia–Taiwan 2020!

 

 

 

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top